| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |